Event
Microbot Medical reports multiple LIBERTY account wins after full release
Evidence notes
- The company said new accounts included two ACCESS-PVI pivotal clinical trial sites.
- The announcement framed commercial adoption as validation of LIBERTY in everyday practice.
Company context
Microbot Medical develops LIBERTY, a compact single-use endovascular robotic system designed for remotely operated vascular access and navigation.
Context
- Company
- Microbot Medical
- Segment
- Surgical
- Event type
- Market Signal
- Evidence
- Source linked
- Added to Korthos
- Jun 19, 2026
- Geography
- Hingham, MA · United States